DOCSLIB.ORG

Parallel Expression of Macrophage Metalloelastase (MMP-12) in Duodenal and Skin Lesions of Gut: First Published As 10.1136/Gut.48.4.496 on 1 April 2001

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Parallel Expression of Macrophage Metalloelastase (MMP-12) in Duodenal and Skin Lesions of Gut: First Published As 10.1136/Gut.48.4.496 on 1 April 2001 496 Gut 2001;48:496–502 Parallel expression of macrophage metalloelastase (MMP-12) in duodenal and skin lesions of Gut: first published as 10.1136/gut.48.4.496 on 1 April 2001. Downloaded from patients with dermatitis herpetiformis M T Salmela, SLFPender, T Reunala, T MacDonald, U Saarialho-Kere Abstract intraepithelial lymphocytes.2 The rash and Background—Dermatitis herpetiformis enteropathy improve on a gluten free diet, (DH) is a specific dermatological manifes- implying that DH is a specific skin manifesta- tation of coeliac disease and 80% of DH tion of mainly subclinical coeliac disease patients have gluten sensitive enteropathy (CD).23 manifested by crypt hyperplasia and vil- Matrix metalloproteinases (MMPs) are a lous atrophy. Matrix degradation mediated family of extracellular matrix (ECM) degrad- by collagenase 1 (MMP-1) and stromelysin ing enzymes that are collectively capable of 1 (MMP-3) has previously been implicated degrading essentially all ECM components in the pathobiology of coeliac intestine and and that can further be subdivided into cutaneous DH blisters. collagenases (MMP-1, -8, and -13), gelatinases Aims—To study expression of stromelysin (MMP-2 and -9), stromelysins (MMP-3, -7, 2, metalloelastase, collagenase 3, and mat- -10, and –12), membrane-type MMPs, and rilysin in the intestine and skin of DH other MMPs.45 The extracellular activity of patients. MMPs is regulated by TIMPs 1–4.6 We have Methods—In situ hybridisation using 35S previously reported that expression of MMP-1 labelled cRNA probes was performed on and -3 is enhanced in basal keratinocytes 7 duodenal biopsies of 15 DH patients, three surrounding neutrophil abscesses in DH skin. samples each of control duodenal or Furthermore, when producing experimental jejunal mucosa, fetal ileal explants, le- DH blisters with 50% potassium iodide, uroki- sional DH skin, and 19 serial biopsies of nase plasminogen activator is upregulated at 12 experimental DH blisters. Immunostain- hours, before blisters are seen, while both ing was used to examine type IV collagen, MMP-1 and MMP-3 are abundantly ex- 8 macrophages (CD68), and 92 kDa gelati- pressed in 24 hour biopsies of blisters. In DH, http://gut.bmj.com/ nase (MMP-9) in the specimens. collagenase 1 (MMP-1) and stromelysin 1 Results—Metalloelastase (MMP-12) was (MMP-3) may contribute to formation of blis- abundantly expressed by subepithelial ters by degrading BM components such as type macrophages in both coeliac intestine and VII as well as type IV collagen or laminin 1, spontaneous and induced DH rash. It was respectively. Interestingly, Daum and col- leagues9 have recently demonstrated that these Department of also upregulated in the experimental same MMPs are expressed by subepithelial Dermatology, Helsinki model of coeliac disease (staphylococcal on September 26, 2021 by guest. Protected copyright. University Central endotoxin B stimulated fetal explants). macrophages and fibroblasts in intestinal Hospital, Helsinki, The only other MMP detected was MMP-9 biopsy specimens from patients with CD. Finland which did not colocalise with MMP-12. Tissue transglutaminase (tTG) was recently M T Salmela identified as the endomysial antigen in patients U Saarialho-Kere Conclusions—Upregulation of metallo- 10 elastase is associated with T cell mediated with CD. Patients with DH have elevated immunoglobulin A autoantibodies to tTG Department of immune responses both in the intestine 11 Dermatology, Tampere and skin. In addition to modulating mac- confirming its pathogenic relation with CD. University Hospital, rophage migration, it may contribute to tTG has been shown to be involved in the Tampere, Finland degradation of proteoglycans or basement intermolecular cross linking of type VII colla- T Reunala gen of anchoring fibrils of skin. Interestingly, membrane components in the subepithe- type VII collagen is degraded, at least in Department of lial mucosa. Paediatric (Gut 2001;48:496–502) experimental DH blisters, and expression of Gastroenterology, St both MMP-1 and MMP-3 colocalise in these 8 Bartholomew’s and the Keywords: coeliac disease; metalloproteinase; areas. Royal London School dermatitis herpetiformis The histological changes of CD are charac- of Medicine and terised by deepening of the crypts and flatten- Dentistry, London, UK ing of the villi, and altered turnover of ECM SLFPender Dermatitis herpetiformis (DH) is a chronic 9 T MacDonald has been implicated in these changes. Rapid cutaneous disorder characterised by a blister- collapse of the villus architecture can occur Correspondence to: ing rash on the elbows, knees, and buttocks, Dr U K Saarialho-Kere, and granular IgA deposits in the basement Abbreviations used in this paper: DH, dermatitis Department of Dermatology, membrane (BM) zone.1 Although gastro- herpetiformis; MMPs, matrix metalloproteinases; BM, Helsinki University Central basement membrane; CD, coeliac disease; ECM, Hospital, Meilahdentie 2, intestinal symptoms in DH patients are rare, 00250 Helsinki, Finland. they all have gluten sensitive enteropathy extracellular matrix; SEB, staphylococcal endotoxin B; ulpu.saarialho-kere@helsinki.fi tTG, tissue transglutaminase; IFN-ã, interferon ã; IL, manifested in 80% by crypt hyperplasia or par- interleukin; TNF-á, tumour necrosis factor á; TGF-â, Accepted for publication tial villous atrophy, while the rest have normal transforming growth factor â; GM-CSF, granulocyte 25 September 2000 villous architecture with increased counts of macrophage-colony stimulating factor. www.gutjnl.com MMP-12 in duodenal and skin lesions of patients with dermatitis herpetiformis 497 within hours of administering gliadin to CD Department of Dermatology, Helsinki Univer- patients in vivo.9 Daum and colleagues9 also sity Central Hospital. Informed consent was recently demonstrated in vivo that MMP-1 obtained from individual subjects for all proce- may contribute to degradation of interstitial dures. Gut: first published as 10.1136/gut.48.4.496 on 1 April 2001. Downloaded from collagens and MMP-3 to epithelial cell shed- ding in CD. In an experimental model of IN SITU HYBRIDISATION human fetal small intestine, direct addition of The production and specificity of the antisense activated MMP-3 in explant cultures caused human stromelysin 2, macrophage metallo- collapse of the villi within 24 hours.12 Further- elastase, collagenase 3, and matrilysin probes more, crypt hyperplasia and villous atrophy have been described previously.14 20–22 As a con- rapidly occurred following activation of lamina trol for non-specific hybridisation, sections propria T cells with the bacterial superantigen were hybridised with 35S labelled sense RNA Staphylococcus aureus endotoxin B (SEB).13 We from a bovine tropoelastin cDNA. The validity have shown that various other MMPs such as of this probe as a negative control has been stromelysin 2 (MMP-10), matrilysin (MMP- confirmed by northern23 and in situ hybridisa- 7), collagenase 3 (MMP-13), and macrophage tion24 assays. The cDNAs were transcribed in metalloelastase (MMP-12) are upregulated in vitro using a commercial kit (Promega Corp., another intestinal disorder, inflammatory Madison, Wisconsin, USA) and labelled with bowel disease, characterised by influx of T 35S UTP, as previously described.25 cells, eosinophils, and neutrophils, as well as Following deparaYnisation and rehydration, degradation of the mucosa.14 MMP-10 has a 5 µm sections were pretreated with 1 mg/ml of nearly identical substrate specificity to MMP- proteinase K and washed in 0.1 M trieth- 3.15 MMP-12 is the most elastolytic of the anolamine containing 0.25% acetic anhydride. MMPs but also degrades various other sub- Subsequently, sections were hybridised with strates such as type IV collagen, laminin 1, probes (2.5–5×104 cpm/µl of hybridisation fibronectin, vitronectin, and proteoglycans.16 17 buVer) and washed under stringent conditions, Matrilysin cleaves in vitro collagen type IV, including treatment with RNAse A, as de- proteoglycans, gelatin, aggrecan, fibronectin, scribed previously.25 26 Autoradiography was laminin, tenascin, and elastin.18 Collagenase 3 carried out for 20–40 days. All samples were degrades fibrillar collagens, gelatin, type IV processed in at least two experiments and were collagen, tenascin, and fibronectin.19 The aim independently analysed by two investigators. of this study was to further characterise the Samples previously positive for stromelysin 2 patterns of MMP expression in DH intestine. (chronic wounds), macrophage metalloelastase We compared expression of various MMPs in (sarcoid granulomas), collagenase 3 the intestine and skin of patients with DH, and (squamous cell carcinomas), and matrilysin also used the fetal explant model of enteropa- (sweat gland tumours) were used as positive http://gut.bmj.com/ thy to investigate the link between T cell controls. activation and MMP production. IMMUNOSTAINING Immunostaining was performed using the Methods avidin-biotin-peroxidase complex technique.25 TISSUES Diaminobenzidine or aminoethylcarbazole Fifteen specimens of formalin fixed paraYn (CD20) were used as chromogenic substrates. embedded duodenal biopsies taken during Monoclonal antibodies included MMP-9 (DB- on September 26, 2021 by guest. Protected copyright. upper gastrointestinal endoscopy were ob- 2211; Diabor, Finland)27 and CD68 (KP-1, No tained from the archives of the Department of M814; Dako, Carpinteria, California, USA) to Dermatopathology, University of Helsinki, identify macrophages and type IV collagen Finland. All patients
Load more

Recommended publications
  • Metalloproteinase-9 and Chemotaxis Inflammatory Cell Production of Matrix AQARSAASKVKVSMKF, Induces 5, Α a Site on Laminin
    A Site on Laminin α5, AQARSAASKVKVSMKF, Induces Inflammatory Cell Production of Matrix Metalloproteinase-9 and Chemotaxis This information is current as of September 25, 2021. Tracy L. Adair-Kirk, Jeffrey J. Atkinson, Thomas J. Broekelmann, Masayuki Doi, Karl Tryggvason, Jeffrey H. Miner, Robert P. Mecham and Robert M. Senior J Immunol 2003; 171:398-406; ; doi: 10.4049/jimmunol.171.1.398 Downloaded from http://www.jimmunol.org/content/171/1/398 References This article cites 64 articles, 24 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/171/1/398.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 25, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2003 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology A Site on Laminin ␣5, AQARSAASKVKVSMKF, Induces Inflammatory Cell Production of Matrix Metalloproteinase-9 and Chemotaxis1 Tracy L. Adair-Kirk,* Jeffrey J. Atkinson,* Thomas J.
    [Show full text]
  • Collagenase and Elastase Activities in Human and Murine Cancer Cells and Their Modulation by Dimethylformamide
    University of Rhode Island DigitalCommons@URI Open Access Master's Theses 1983 COLLAGENASE AND ELASTASE ACTIVITIES IN HUMAN AND MURINE CANCER CELLS AND THEIR MODULATION BY DIMETHYLFORMAMIDE David Ray Olsen University of Rhode Island Follow this and additional works at: https://digitalcommons.uri.edu/theses Recommended Citation Olsen, David Ray, "COLLAGENASE AND ELASTASE ACTIVITIES IN HUMAN AND MURINE CANCER CELLS AND THEIR MODULATION BY DIMETHYLFORMAMIDE" (1983). Open Access Master's Theses. Paper 213. https://digitalcommons.uri.edu/theses/213 This Thesis is brought to you for free and open access by DigitalCommons@URI. It has been accepted for inclusion in Open Access Master's Theses by an authorized administrator of DigitalCommons@URI. For more information, please contact [email protected]. COLLAGENASE AND ELASTASE ACTIVITIES IN HUMAN AND MURINE CANCER CELLS AND THEIR MODULATION BY DIMETHYLFORMAMIDE BY DAVID RAY OLSEN A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE IN PHARMACOLOGY AND TOXICOLOGY UNIVERSITY OF RHODE ISLAND 1983 MASTER OF SCIENCE THESIS OF DAVID RAY OLSEN APPROVED: Thesis Committee / / Major Professor / • l / .r Dean of the Graduate School UNIVERSITY OF RHODE ISLAND 1983 ABSTRACT Olsen, David R.; M.S., University of Rhode Island, 1983. Collagenase and Elastase Activities in Human and Murine Cancer Cells and Their Modulation by Dimethyl­ formamide. Major Professor: Dr. Clinton O. Chichester. The transformation from carcinoma in situ to in­ vasive carcinoma occurs when tumor cells traverse extra­ cellular matracies allowing them to move into paren­ chymal tissues. Tumor invasion may be aided by the secretion of collagen and elastin degrading proteases from tumor and tumor-associated cells.
    [Show full text]
  • Untangling the Protease Web in COPD: Metalloproteinases in the Silent Zone
    Editorial Thorax: first published as 10.1136/thoraxjnl-2015-208204 on 14 January 2016. Downloaded from derived proteases capable of generating Untangling the protease web in COPD: leucocyte chemotaxins and activating TGFβ.12 Measures of small airway disease metalloproteinases in the silent zone were associated with a different MMP sig- nature again, comprising MMP-3, MMP-7, Simon R Johnson MMP-8, MMP-9 and MMP-10. The stron- gest association being with MMP-8. The differing MMP profiles associated with The idea that unregulated protease activity unfortunately the reality is not that small airway obstruction and emphysema underlies the pathogenesis of COPD has straightforward. The rapidly expanding highlight that small airway remodelling is been prominent since the recognition that number of non-ECM MMP substrates has required for airflow obstruction in COPD, genetic loss of α1 antitrypsin led to highlighted a large number of biological independent of loss of elastic recoil due to unregulated neutrophil elastase activity processes modified by MMPs and created emphysema. and premature emphysema.1 Increased potential new opportunities to intervene The challenge is to understand how proteolysis by other proteases, particularly therapeutically in COPD. For example, these tissue-remodelling enzymes contrib- the matrix metalloproteinases (MMPs), proteomic-based interrogation of animal ute to the airway pathology of COPD. has since been implicated in COPD. The models of inflammation has identified This study highlights the need to consider MMPs are a family of over 20 zinc- around 150 discrete protein substrates of the roles of proteases in other aspects of dependent endopeptidases, initially identi- MMP-12 in vivo.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • An Investigation of ADAM-Like Decysin 1 in Macrophage-Mediated Inflammation and Crohn’S Disease
    An Investigation of ADAM-like Decysin 1 in Macrophage-mediated Inflammation and Crohn’s Disease By Nuala Roisin O’Shea A thesis submitted to UCL for the degree of Doctor of Philosophy Division of Medicine Declaration I, Nuala Roisin O’Shea, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. 2 Abstract Crohn’s disease (CD) is now recognised as a defective host response to bacteria in genetically susceptible individuals. The role of innate immunity and impaired bacterial clearance are widely accepted. In this thesis the role of ADAM-like, Decysin-1 (ADAMDEC1) in macrophage-mediated inflammation and gut mucosal immunity is explored. Using transcriptomic analysis of monocyte derived macrophages (MDM) ADAMDEC1 was identified as grossly under expressed in a subset of patients with CD. ADAMDEC1 was found to be highly selective to the intestine, peripheral blood monocyte-derived and lamina propria macrophages. It was shown to be an inflammatory response gene, upregulated in response to bacterial antigens and inflammation. ADAMDEC1 was expressed in prenatal and germ free mice, demonstrating exposure to a bacterial antigen is not a prerequisite for expression. Adamdec1 knock out mice were used to investigate the role of ADAMDEC1 in vivo. Adamdec1-/- mice displayed an increased susceptibility to dextran sodium sulphate (DSS), Citrobacter rodentium and Salmonella typhimurium induced colitis. In Adamdec1-/- mice, bacterial translocation and systemic infection were increased in bacterial models of colitis. These results suggest that individuals with grossly attenuated expression of ADAMDEC1 may be at an increased risk of developing intestinal inflammation as a consequence of an impaired ability to handle enteric bacterial pathogens.
    [Show full text]
  • An Adverse Role for Matrix Metalloproteinase 12 After Spinal Cord Injury in Mice
    The Journal of Neuroscience, November 5, 2003 • 23(31):10107–10115 • 10107 Development/Plasticity/Repair An Adverse Role for Matrix Metalloproteinase 12 after Spinal Cord Injury in Mice Jennifer E. A. Wells,1 Tiffany K. Rice,1 Robert K. Nuttall,3 Dylan R. Edwards,3 Hakima Zekki,4 Serge Rivest,4 V. Wee Yong1,2 Departments of 1Clinical Neurosciences and 2Oncology, Faculty of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada, 3School of Biological Sciences, University of East Anglia, Norwich NR4 7TJ, United Kingdom, and 4Laboratory of Molecular Endocrinology and Department of Anatomy and Physiology, Laval University, Quebec, Quebec G1V 4G2, Canada We investigated the role of matrix metalloproteinases (MMPs) in acute spinal cord injury (SCI). Transcripts encoding 22 of the 23 known mammalian MMPs were measured in the mouse spinal cord at various time points after injury. Although there were significant changes in the expression levels of multiple MMPs, MMP-12 was increased 189-fold over normal levels, the highest of all MMPs examined. To evaluate the role of MMP-12 in SCI, spinal cord compression was performed in wild-type (WT) and MMP-12 null mice. Behavioral analyses were conducted for 4 weeks using the Basso–Beattie–Bresnahan (BBB) locomotor rating scale as well as the inclined plane test. The results show that MMP-12 null mice exhibited significantly improved functional recovery compared with WT controls. Twenty-eight days after injury, the BBB score in the MMP-12 group was 7, representing extensive movement of all three hindlimb joints, compared with 4 in the WT group, representing only slight movement of these joints.
    [Show full text]
  • (MMP10) Moderates Inflammation by Controlling Macrophage Activation
    Stromelysin-2 (MMP10) Moderates Inflammation by Controlling Macrophage Activation This information is current as Ryan S. McMahan, Timothy P. Birkland, Kate S. Smigiel, of September 26, 2021. Tyler C. Vandivort, Maryam G. Rohani, Anne M. Manicone, John K. McGuire, Sina A. Gharib and William C. Parks J Immunol 2016; 197:899-909; Prepublished online 17 June 2016; doi: 10.4049/jimmunol.1600502 Downloaded from http://www.jimmunol.org/content/197/3/899 Supplementary http://www.jimmunol.org/content/suppl/2016/06/16/jimmunol.160050 Material 2.DCSupplemental http://www.jimmunol.org/ References This article cites 72 articles, 15 of which you can access for free at: http://www.jimmunol.org/content/197/3/899.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 26, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Stromelysin-2 (MMP10) Moderates Inflammation by Controlling Macrophage Activation Ryan S.
    [Show full text]
  • A Therapeutic Role for MMP Inhibitors in Lung Diseases?
    ERJ Express. Published on June 9, 2011 as doi: 10.1183/09031936.00027411 A therapeutic role for MMP inhibitors in lung diseases? Roosmarijn E. Vandenbroucke1,2, Eline Dejonckheere1,2 and Claude Libert1,2,* 1Department for Molecular Biomedical Research, VIB, Ghent, Belgium 2Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium *Corresponding author. Mailing address: DBMR, VIB & Ghent University Technologiepark 927 B-9052 Ghent (Zwijnaarde) Belgium Phone: +32-9-3313700 Fax: +32-9-3313609 E-mail: [email protected] 1 Copyright 2011 by the European Respiratory Society. A therapeutic role for MMP inhibitors in lung diseases? Abstract Disruption of the balance between matrix metalloproteinases and their endogenous inhibitors is considered a key event in the development of pulmonary diseases such as chronic obstructive pulmonary disease, asthma, interstitial lung diseases and lung cancer. This imbalance often results in elevated net MMP activity, making MMP inhibition an attractive therapeutic strategy. Although promising results have been obtained, the lack of selective MMP inhibitors together with the limited knowledge about the exact functions of a particular MMP hampers the clinical application. This review discusses the involvement of different MMPs in lung disorders and future opportunities and limitations of therapeutic MMP inhibition. 1. Introduction The family of matrix metalloproteinases (MMPs) is a protein family of zinc dependent endopeptidases. They can be classified into subgroups based on structure (Figure 1), subcellular location and/or function [1, 2]. Although it was originally believed that they are mainly involved in extracellular matrix (ECM) cleavage, MMPs have a much wider substrate repertoire, and their specific processing of bioactive molecules is their most important in vivo role [3, 4].
    [Show full text]
  • Elastin Fragments Drive Disease Progression in a Murine Model of Emphysema
    Elastin fragments drive disease progression in a murine model of emphysema A. McGarry Houghton, … , obert M. Senior,, Steven D. Shapiro J Clin Invest. 2006;116(3):753-759. https://doi.org/10.1172/JCI25617. Research Article Inflammation Mice lacking macrophage elastase (matrix metalloproteinase-12, or MMP-12) were previously shown to be protected from the development of cigarette smoke–induced emphysema and from the accumulation of lung macrophages normally induced by chronic exposure to cigarette smoke. To determine the basis for macrophage accumulation in experimental emphysema, we now show that bronchoalveolar lavage fluid from WT smoke-exposed animals contained chemotactic activity for monocytes in vitro that was absent in lavage fluid from macrophage elastase–deficient mice. Fractionation of the bronchoalveolar lavage fluid demonstrated the presence of elastin fragments only in the fractions containing chemotactic activity. An mAb against elastin fragments eliminated both the in vitro chemotactic activity and cigarette smoke–induced monocyte recruitment to the lung in vivo. Porcine pancreatic elastase was used to recruit monocytes to the lung and to generate emphysema. Elastin fragment antagonism in this model abrogated both macrophage accumulation and airspace enlargement. Find the latest version: https://jci.me/25617/pdf Research article Elastin fragments drive disease progression in a murine model of emphysema A. McGarry Houghton,1 Pablo A. Quintero,1 David L. Perkins,2 Dale K. Kobayashi,3 Diane G. Kelley,3 Luiz A. Marconcini,1 Robert P. Mecham,4 Robert M. Senior,3,4 and Steven D. Shapiro1 1Division of Pulmonary and Critical Care Medicine and 2Division of Nephrology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA.
    [Show full text]
  • Peptides and Peptidomimetics As Inhibitors of Enzymes Involved in Fibrillar Collagen Degradation
    materials Review Peptides and Peptidomimetics as Inhibitors of Enzymes Involved in Fibrillar Collagen Degradation Patrycja Ledwo ´n 1,2 , Anna Maria Papini 3 , Paolo Rovero 2,* and Rafal Latajka 1,* 1 Department of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, 50-370 Wroclaw, Poland; [email protected] 2 Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Neurosciences, Psychology, Drug Research and Child Health-Section of Pharmaceutical Sciences and Nutraceutics, University of Florence, 50019 Sesto Fiorentino, Firenze, Italy 3 Interdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Chemistry “Ugo Schiff”, University of Florence, 50019 Sesto Fiorentino, Firenze, Italy; annamaria.papini@unifi.it * Correspondence: paolo.rovero@unifi.it (P.R.); [email protected] (R.L.) Abstract: Collagen fibres degradation is a complex process involving a variety of enzymes. Fibrillar collagens, namely type I, II, and III, are the most widely spread collagens in human body, e.g., they are responsible for tissue fibrillar structure and skin elasticity. Nevertheless, the hyperactivity of fibrotic process and collagen accumulation results with joints, bone, heart, lungs, kidneys or liver fibroses. Per contra, dysfunctional collagen turnover and its increased degradation leads to wound healing disruption, skin photoaging, and loss of firmness and elasticity. In this review we described the main enzymes participating in collagen degradation pathway, paying particular attention to enzymes degrading fibrillar collagen. Therefore, collagenases (MMP-1, -8, and -13), elastases, and cathepsins, together with their peptide and peptidomimetic inhibitors, are reviewed. This information, related Citation: Ledwo´n,P.; Papini, A.M.; to the design and synthesis of new inhibitors based on peptide structure, can be relevant for future Rovero, P.; Latajka, R.
    [Show full text]
  • Full Text (PDF)
    BACK TO BASICS | PROTEASES IN LUNG DISEASE Protean proteases: at the cutting edge of lung diseases Clifford Taggart1, Marcus A. Mall2,3,4, Gilles Lalmanach5, Didier Cataldo6, Andreas Ludwig7, Sabina Janciauskiene8, Nicole Heath3,4,9, Silke Meiners10, Christopher M. Overall11, Carsten Schultz4,9, Boris Turk12 and Keren S. Borensztajn13,14 Affiliations: 1Airway Innate Immunity Research group (AiiR), Centre for Experimental Medicine, Queen’s University Belfast, UK. 2Dept of Translational Pulmonology, University of Heidelberg, Heidelberg, Germany. 3Division of Pediatric Pulmonology & Allergy and Cystic Fibrosis Center, Dept of Pediatrics, University of Heidelberg, Heidelberg, Germany. 4Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany. 5INSERM UMR1100 Centre d’Etude des Pathologies Respiratoires (CEPR), Equipe: Mécanismes Protéolytiques dans l’Inflammation, Université François Rabelais, Tours, France. 6Laboratory of Tumors and Development and Dept of Respiratory Diseases, University of Liege, Liege, Belgium. 7Inflammation Pharmacology Research Group, Institute of Pharmacology and Toxicology, RWTH Aachen University, Aachen, Germany. 8Dept of Respiratory Medicine, a member of The German Center for Lung Research (DZL), Hannover Medical School, Hannover, Germany. 9European Molecular Biology Laboratory (EMBL), Heidelberg, Germany. 10Comprehensive Pneumology Center (CPC), University Hospital, Ludwig- Maximilians University, Helmholtz Zentrum München, Member of the German Center for
    [Show full text]
  • Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases
    Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases Alan J. Barrett Neil D. Rawlings J. Fred Woessner Editor biographies xxi Contributors xxiii Preface xxxi Introduction ' Abbreviations xxxvii ASPARTIC PEPTIDASES Introduction 1 Aspartic peptidases and their clans 3 2 Catalytic pathway of aspartic peptidases 12 Clan AA Family Al 3 Pepsin A 19 4 Pepsin B 28 5 Chymosin 29 6 Cathepsin E 33 7 Gastricsin 38 8 Cathepsin D 43 9 Napsin A 52 10 Renin 54 11 Mouse submandibular renin 62 12 Memapsin 1 64 13 Memapsin 2 66 14 Plasmepsins 70 15 Plasmepsin II 73 16 Tick heme-binding aspartic proteinase 76 17 Phytepsin 77 18 Nepenthesin 85 19 Saccharopepsin 87 20 Neurosporapepsin 90 21 Acrocylindropepsin 9 1 22 Aspergillopepsin I 92 23 Penicillopepsin 99 24 Endothiapepsin 104 25 Rhizopuspepsin 108 26 Mucorpepsin 11 1 27 Polyporopepsin 113 28 Candidapepsin 115 29 Candiparapsin 120 30 Canditropsin 123 31 Syncephapepsin 125 32 Barrierpepsin 126 33 Yapsin 1 128 34 Yapsin 2 132 35 Yapsin A 133 36 Pregnancy-associated glycoproteins 135 37 Pepsin F 137 38 Rhodotorulapepsin 139 39 Cladosporopepsin 140 40 Pycnoporopepsin 141 Family A2 and others 41 Human immunodeficiency virus 1 retropepsin 144 42 Human immunodeficiency virus 2 retropepsin 154 43 Simian immunodeficiency virus retropepsin 158 44 Equine infectious anemia virus retropepsin 160 45 Rous sarcoma virus retropepsin and avian myeloblastosis virus retropepsin 163 46 Human T-cell leukemia virus type I (HTLV-I) retropepsin 166 47 Bovine leukemia virus retropepsin 169 48
    [Show full text]